Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The University of Mississippi Medical Center currently has 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are spread across 2 distinct art units, indicating a focus on different technical areas within the biotech field. The university is engaging with 4 distinct examiners for these cases.
Huong Q. Nguyen is the busiest examiner for this portfolio, although she is responsible for 1 pending office action. Since there are 4 pending actions, the workload is distributed with each examiner handling a case. This lack of examiner concentration means that the university must manage separate examiner relationships simultaneously.
The 2 distinct art units involved suggest that the pending office actions are likely grouped into technical clusters. With 4 distinct examiners, the university faces a variety of perspectives even within those art units. Practitioners should be prepared for diverse feedback across the active matters in the Biotechnology & Pharmaceuticals portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (50%) |
| §112 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, HUONG Q | 1 | 45.7% | +43.9% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
| MONTGOMERY, MELISSA JO | 1 | 15.4% | +40.0% |
| NIEBAUER, RONALD T | 1 | 40.8% | +34.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17710984 | VIRTUAL IMMERSIVE SENSORIMOTOR DEVICE AND METHODS TO DETECT NEUROLOGICAL IMPAIRMENTS | MONTGOMERY, MELISSA JO | 98d overdue |
| 18842760 | METHOD AND DEVICE FOR IMPROVED CLINICAL VESTIBULAR TESTING | NGUYEN, HUONG Q | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17710984 | VIRTUAL IMMERSIVE SENSORIMOTOR DEVICE AND METHODS TO DETECT NEUROLOGICAL IMPAIRMENTS | MONTGOMERY, MELISSA JO | 98d overdue |
| 16104037 | Composition and Method for Therapeutic Agent Delivery During Pregnancy | NIEBAUER, RONALD T | 60d overdue |
| 18373749 | METHOD FOR THE PRODUCTION OF PRECISELY SIZED MACRO- AND MICRO-ELP CONTAINING PARTICLES FOR THE DELIVERY OF THERAPEUTIC AGENTS | REYNOLDS, FRED H | 3d overdue |
| 18842760 | METHOD AND DEVICE FOR IMPROVED CLINICAL VESTIBULAR TESTING | NGUYEN, HUONG Q | — |
| Art Unit | Apps |
|---|---|
| 1658 | 2 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18842760 | METHOD AND DEVICE FOR IMPROVED CLINICAL VESTIBULAR TESTING | NGUYEN, HUONG Q | — | §101§103§112 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18373749 | METHOD FOR THE PRODUCTION OF PRECISELY SIZED MACRO- AND MICRO-ELP CONTAINING PARTICLES FOR THE DELIVERY OF THERAPEUTIC AGENTS | REYNOLDS, FRED H | 1658 | §103§112DP | Non-Final OA | 3d overdue | Pending | Sep 27, 2023 |
| 17710984 | VIRTUAL IMMERSIVE SENSORIMOTOR DEVICE AND METHODS TO DETECT NEUROLOGICAL IMPAIRMENTS | MONTGOMERY, MELISSA JO | 3791 | §101§103§112 | Non-Final OA | 98d overdue | Pending | Mar 31, 2022 |
| 16104037 | Composition and Method for Therapeutic Agent Delivery During Pregnancy | NIEBAUER, RONALD T | 1658 | §112 | Final Rejection | 60d overdue | Pending | Aug 16, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial